Correlation Between Pfizer and IShares Intermediate

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and IShares Intermediate at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and IShares Intermediate into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and iShares Intermediate GovernmentCredit, you can compare the effects of market volatilities on Pfizer and IShares Intermediate and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of IShares Intermediate. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and IShares Intermediate.

Diversification Opportunities for Pfizer and IShares Intermediate

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between Pfizer and IShares is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and iShares Intermediate Governmen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Intermediate and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with IShares Intermediate. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Intermediate has no effect on the direction of Pfizer i.e., Pfizer and IShares Intermediate go up and down completely randomly.

Pair Corralation between Pfizer and IShares Intermediate

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the IShares Intermediate. In addition to that, Pfizer is 6.56 times more volatile than iShares Intermediate GovernmentCredit. It trades about -0.05 of its total potential returns per unit of risk. iShares Intermediate GovernmentCredit is currently generating about 0.16 per unit of volatility. If you would invest  10,367  in iShares Intermediate GovernmentCredit on December 28, 2024 and sell it today you would earn a total of  186.00  from holding iShares Intermediate GovernmentCredit or generate 1.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pfizer Inc  vs.  iShares Intermediate Governmen

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
iShares Intermediate 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Intermediate GovernmentCredit are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, IShares Intermediate is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pfizer and IShares Intermediate Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and IShares Intermediate

The main advantage of trading using opposite Pfizer and IShares Intermediate positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, IShares Intermediate can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Intermediate will offset losses from the drop in IShares Intermediate's long position.
The idea behind Pfizer Inc and iShares Intermediate GovernmentCredit pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data